The Wegovy Pill Is Here: What It Costs and How It Compares
Market snapshot: The oral Wegovy pill (semaglutide 25mg) hit pharmacies in January 2026 at $149–$299/mo self-pay through NovoCare. It eliminates needles and refrigeration but requires a 30-minute fasting window each morning. Clinical trials showed roughly 13.6% weight loss at 64 weeks — slightly less than injectable Wegovy's 15%.
The FDA approved the Wegovy pill on December 22, 2025, making it the first oral GLP-1 medication specifically indicated for weight loss. It's the same active ingredient — semaglutide — as the injectable version, just in a daily tablet instead of a weekly injection.
It's available now at CVS, Costco, Walgreens, and through telehealth platforms like Ro, GoodRx, and Hims & Hers. Here's what you need to know about how it works, what it costs, and how it stacks up against the alternatives.
How the Wegovy Pill Works
Oral Wegovy uses the same semaglutide molecule as the injection, but at different doses. The pill dose ladder runs 1.5mg → 4mg → 9mg → 25mg (taken daily), compared to the injectable ladder that tops out at 2.4mg weekly (or 7.2mg for the newer HD version).
The higher oral doses compensate for lower bioavailability — your body absorbs less semaglutide from a pill than from an injection. Despite the different numbers, the clinical effect is comparable.
⚠️ Important: The Wegovy pill requires a 30-minute fasting window after taking it. You take it first thing in the morning with a small sip of water, then wait at least 30 minutes before eating, drinking, or taking other medications. This is a meaningful lifestyle constraint that some patients find difficult.
Wegovy Pill Pricing (May 2026)
| Dose | Self-Pay Price | Notes |
|---|---|---|
| 1.5mg (starter) | $149/mo | Via NovoCare Pharmacy |
| 4mg | $149/mo until 8/31/26 | Increases to $199/mo after August 2026 |
| 9mg | $299/mo | Maintenance dose tier |
| 25mg (target) | $299/mo | Maximum weight-loss dose |
| With insurance | As low as $25/mo | With Novo savings card |
| Medicare (July 2026) | $50/mo | Via Medicare GLP-1 Bridge program |
Novo Nordisk also announced in February 2026 that the list price for all Wegovy and Ozempic products will drop to $675/month effective January 1, 2027 — a 50% reduction for Wegovy. However, this does not affect the self-pay DTC pricing listed above.
How Does It Compare to Injectable Wegovy?
| Feature | Wegovy Pill | Wegovy Injectable |
|---|---|---|
| Weight loss (trials) | ~13.6% at 64 weeks (OASIS 4) | ~15% at 68 weeks (STEP 1) |
| Administration | Daily pill | Weekly injection |
| Refrigeration | No | Yes (36–46°F) |
| Fasting required | Yes — 30 min morning fast | No |
| Self-pay starter | $149/mo | $199/mo (first 2 months through 6/30/26) |
| Self-pay maintenance | $299/mo | $349/mo (then $399 for HD 7.2mg) |
| Side effects | Similar GI profile | Similar GI profile |
The pill is about 1.4 percentage points less effective than the injection in clinical trials, but eliminates needles and refrigeration. For patients whose primary barrier is needle anxiety or cold chain logistics, the tradeoff is worth it. For patients who want maximum weight loss, the injectable edge still matters.
How Does It Compare to Compounded Semaglutide?
The Wegovy pill creates an interesting tension in the market. At $149–$299/mo, it's priced competitively with compounded semaglutide ($99–$350/mo range), while carrying full FDA approval.
| Option | Monthly Cost | FDA Status | Key Advantage |
|---|---|---|---|
| GobyMeds (compounded) | $99/mo | Not FDA-approved | Lowest cost |
| Yucca Health (compounded) | $146/mo (6-mo plan) | Not FDA-approved | Flat pricing, no dose tiers |
| Wegovy Pill (brand) | $149–$299/mo | FDA-approved | Full regulatory approval, no needles |
| Embody (compounded) | $149/$299/mo | Not FDA-approved | Physician-supervised, injectable |
| Wegovy Injectable (brand) | $349/mo | FDA-approved | Highest efficacy (~15% loss) |
For patients who value FDA approval and want to avoid injections, the Wegovy pill is now the clear choice. For patients where cost is the primary driver, compounded options from verified providers still offer savings at the lower dose tiers.
Who Should Consider the Wegovy Pill?
The oral formulation makes sense for patients who have needle anxiety or injection fatigue, those who travel frequently and want to skip cold-chain logistics, patients whose insurance now covers oral Wegovy (many commercial plans added it quickly), and Medicare beneficiaries who will gain access at $50/mo through the GLP-1 Bridge starting July 1, 2026.
It's less ideal for patients who can't commit to the 30-minute morning fasting window, or for those who want maximum weight loss (the injectable still has a slight clinical edge).
What About Foundayo?
Eli Lilly's oral GLP-1, Foundayo (orforglipron), was FDA-approved on April 1, 2026 with no food or water restrictions — a meaningful advantage over the Wegovy pill's 30-minute fast. We cover Foundayo in detail in a separate article.
Compare Verified Providers
Sesame Care
$175 CPA — Brand-Name GLP-1s
Access to FDA-approved Wegovy, Zepbound, and Foundayo through licensed providers. Brand-name medications only.
Learn More Paid linkEmbody
$149 first month / $299 refills
Injectable semaglutide. Physician-supervised with regular check-ins.
Learn More Paid linkCompounded medications are not FDA-approved.
GobyMeds
$99/mo semaglutide
LegitScript certified, 503A+503B pharmacies. Free consult, free shipping.
Learn More Paid linkCompounded medications are not FDA-approved.
Compare All GLP-1 Providers Side by Side
See pricing, medications, and ratings for verified telehealth providers.
View Provider Comparison →Sources
- Novo Nordisk press release: Wegovy pill FDA approval, December 22, 2025.
- OASIS 4 trial data. New England Journal of Medicine.
- NovoCare Pharmacy pricing, verified May 2026.
- Wegovy.com cost and coverage page, verified May 2026.
- Novo Nordisk press release: list price reduction to $675/mo effective January 1, 2027.
- CMS Medicare GLP-1 Bridge announcement, 2026.
Affiliate Disclosure: Some links on this page are paid affiliate links. If you sign up through them, we may earn a commission at no extra cost to you. This does not influence our editorial content or sourcing.
Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
FDA Notice: Compounded medications referenced in this article are not FDA-approved. Only brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo) carry FDA approval for their indicated uses.